These emerging medications , Tirzepatide , represent a remarkable advancement in treating obesity and possibly other ailments . They all are categorized as GLP-1 pathway agonists , indicating they https://monicadabf412535.blogoxo.com/41930536/tirzepatide-a-deep-dive-into-glp-1-agents